Utilising digital health to improve medication-related quality of care for hypertensive patients: An integrative literature review

Table 4 Challenges in implementing digital health intervention for hypertensive patients

Challenges
Limited resources[23]
Technological issues[39]
Collaboration between stakeholders[39]
Discrepancy between BP values obtained from different setting[48] i.e., research setting, home and clinic and socioeconomic status, i.e., income status, education, socioeconomic, access to technology, tech-savvy and motivational biases
Self-limited rash at the wearable sensor site[43,49]
Imprecise message for reminder[51]
Interpatient variation in medication timeline and frequency[42]
Different email addresses, for example, participants who used Yahoo email were more likely to complete the intervention than users of other email domains[50]
Overlap in content of a DTx and conventional interventions[25,26]
Patients’ variable clinic visits and the lack of standardization of the blood pressure measurement[28]
Lack of expert-driven e-counselling protocol[40]
Sustainability of intervention, for example, SMASK patients returned the Bluetooth blood pressure devices and smartphones after the end of clinical trial[22]
Lack of clinical measurement[41]
SMSs sent were reached family members rather than the patients themselves[32,53,54]

BP: Blood pressure; DTx: Digital therapeutic; SMASK: Smartphone Medication Adherence Saves Kidneys; SMSs: Short Message Services.